For citations:
Fedyanin MY, Ehlsnukaeva КM, Demidova IA, Stroyakovskiy DL, Shelygin YA, Tsukanov АS, Panina МV, Shubin VР, Moiseenko FV, Karpenko EY, Bolotina LV, Kudryavtseva AV, Filipenko МL, Oskorbin IP, Vladimirova LY, Timoshkina NN, Kit ОI, Stroganova АМ, Dranko SL, Senderovich АI, Tryakin АА, Tjulandin SА. Incidence and prognostic factors in patents (pts) with mutant BRAF (mBRAF) metastatic colorectal cancer (mCRC) in Russia. Meditsinskiy sovet = Medical Council. 2021;(4S):52-63. (In Russ.) https://doi.org/10.21518/2079-701X-2021-4S-52-63